SHL Medical and SteriPack Group have formed a non-exclusive strategic partnership to establish a pre-validated final assembly service in Poland. This collaboration will enhance supply chain flexibility for their customers and extend high-quality CMO options to Europe, in addition to SHL Medical’s existing services in the United States.
“This partnership is a significant addition to the Molly® platform value proposition. We share common values with SteriPack, from focus on the customer to a commitment to quality, making the decision to collaborate straightforward”.
Markus Puusepp, Chief Growth Officer at SHL Medical, expressed his excitement about the partnership with SteriPack, stating:
Understanding the significance of adaptability and speed-to-market, particularly in clinical production, the collaboration with SteriPack will provide SHL Medical’s clients with extremely flexible and customized final assembly and packaging solutions. This is especially advantageous for handling small batches in clinical supply and specialized markets such as rare diseases. With a focus on the comprehensive capabilities of the Molly platform, SHL Medical aims to deliver tailored solutions that ensure improved service, faster timelines, and a more efficient supply chain for its diverse customer base.
”SteriPack Group looks forward to supporting SHL Medical and their customers in providing quality and flexible solutions to a fast- moving market. With an emphasis on creating service solutions designed around specific customer requirements, this partnership will make the process of working with the Molly® platform an easy decision”.
John Ward, VP Pharmaceutical Solutions at SteriPack Group, shared his thoughts:
About SHL Medical
SHL Medical is a world-leading provider of advanced drug delivery systems, serving as the preferred partner for many top pharmaceutical and biotech companies. With its commitment to enabling patients’ independence, SHL Medical offers patient-centric solutions for autoinjectors, pen injectors, and innovative specialty delivery systems for large-volume and high-viscosity formulations. Additionally, the company provides final assembly, labeling, and packaging solutions for its drug delivery systems.
With the growing popularity of home therapy, SHL Medical has expanded its efforts in the digital healthcare sector to enhance the drug delivery ecosystem.
With locations in Switzerland, Taiwan, Sweden, and the US, SHL Medical’s global team works together seamlessly to utilize its extensive in-house manufacturing capabilities. Their solutions are tailored to each project, with a focus on sustainability to contribute to a cleaner environment.
For more information, please visit www.shl-medical.com.
– You can find the picture at AP –
About SteriPack Group
SteriPack Group is a leading contract packing and manufacturing organization that serves the pharmaceutical and medical device sectors globally. Their services include device design and development, final assembly, labelling, secondary packing, serialisation, and aggregation of injectable formats such as vials, pre-filled syringes, and autoinjectors. They specialize in tailored customer-focused solutions for small to medium-sized batch volumes required for targeted therapies and clinical trials. SteriPack is a trusted partner to top global pharmaceutical companies, known for their cleanroom assembly and labelling, secondary packing services, and significant investment in growing cold chain storage capacity.
Treść pochodzi z serwisu: pap-mediaroom.pl
